Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Stem Cell Research Moving Forward Despite Limited Lines

June 8, 2004

By Aaron Lorenzo

Inhibitex Gains $35M After Dropping IPO Share Price

June 7, 2004

By Aaron Lorenzo

SeraCare Paying $14.3M To Buy Genomics Collaborative

June 7, 2004

By Aaron Lorenzo

Inhibitex Gains $35M After Dropping IPO Share Price

June 7, 2004

By Aaron Lorenzo

SeraCare Paying $14.3M To Buy Genomics Collaborative

June 7, 2004

By Aaron Lorenzo

Panacos, Vitex Merging In $27M Stock Exchange, Plus Milestones

June 4, 2004

By Aaron Lorenzo

Panacos, Vitex Merging In $27M Stock Exchange, Plus Milestones

June 4, 2004

By Aaron Lorenzo

Alkermes, Genentech Dropping Nutropin Depot From Portfolios

June 3, 2004

By Aaron Lorenzo

Alkermes, Genentech Dropping Nutropin Depot From Portfolios

June 3, 2004

By Aaron Lorenzo

ARYx Raises $55M To Fund Development Of Safer Drugs

June 2, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.